期刊文献+

Down综合征并发先天性心脏病的临床分析

Clinical analysis of Down syndrome with congenital heart diseases
下载PDF
导出
摘要 目的:总结分析Down综合征(Down’s syndrome)并发的先天性心脏病畸形及血流动力学资料。方法:2008年7月-2012年10月,采用经胸二维超声心动图并彩色多普勒显像及右心导管/心血管造影检查方法,诊断36例并发先心病的Down综合征患者,本文通过36例临床资料分析,探讨Down综合征并发的先心病畸形及其血流动力学。结果:36例患者中室间隔缺损(VSD)10例,房室间隔缺损(AVSD)6例,动脉导管未闭(PDA)6例,房间隔缺损(ASD)2例,ASD+PDA2例,ASD+VSD1例,ASD+PDA+VSD1例,VSD+PDA4例,PDA十二叶主动脉瓣(BAV)1例,法洛四联症(TOF)2例,TOF+ASD1例,18例有肺动脉高压者,其中5例为阻力型肺动脉高压。结论:①Down综合征并发的心血管畸形中,以VSD、AVSD和PDA最为常见,并常并发ASD、TOF。②在无肺动脉狭窄的患者中,约50%并发有肺动脉高压。 AIM: To analyze congenital heart deformity and hemodynamic data of Down syndrome. METHODS : Clinical data of Down' s syndrome with congenital heart disease and its hemodynamics were analyzed in 36 patients diagnosed with congenital heart disease patients with Down syndrome by transtho- racic two-dimensional echoeardiography, color Doppler flow imaging and right heart catheterization or angiocardiography from July 2008 to October 2012. RESULTS: Among the 36 cases, there were ten patients with VSD, six patients with AVSD, six patients with PDA, two patients with ASD, two cases with ASD + PDA, one case with ASD + VSD, one patient with ASD + PDA + VSD, four patients with VSD + PDA, one patient with PDA + BAV, two patients with TOF 2, and once patient with TOF + ASD. Eighteen patients had pulmonary hypertension including five cases of resistant pulmonary arterial hyper- tension. CONCLUSION: In cardiovascular malformations with Down syndrome, VSD (28%), AVSD ( 17% ) and PDA ( 17% ) are most common and are often associated with ASD or TOF. In patients with- out pulmonary artery stenosis, about half are complicated with pulmonary artery hypertension.
出处 《心脏杂志》 CAS 2014年第1期43-45,55,共4页 Chinese Heart Journal
关键词 DOWN综合征 先天性心脏病 心脏畸形 心导管检查 肺动脉高压 Down syndrome congenital heart disease cardiac abnormalities cardiac catheterization pulmonary arterial hypertension
  • 相关文献

参考文献1

二级参考文献17

  • 1Paciocco G, Martinez FJ, Bossone E, et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J, 2001, 17:647-652.
  • 2Camargo VM, Martins Bdo C, Jardim C, et al. Validation of a treadmill six-minute walk test protocol for the evaluation of patients with pulmonary arterial hypertension. J Bras Pneumol, 2009, 35 : 423 -430.
  • 3Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology ( ESC ), European Respiratory Society (ERS), International Society of Heart and Lung Transplantation (ISHLT) , et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J, 2009, 34: 1219-1263.
  • 4McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation TaskForce on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association. J Am Coil Cardiol, 2009, 53:1573-1619.
  • 5McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines. Chest, 2004, 126 : 14S-34S.
  • 6Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the Eurppean Society of Cardilogy. Eur Heart J, 2004, 25: 2243- 997R.
  • 7ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six- minute walk test. Am J Respir Crit Care Med, 2002, 166: 111- 117.
  • 8Berger RM, Beghetti M, Gali~ N, et al. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo- controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis. Int J Cardiol, 2010, 144:373-378.
  • 9Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest, 2007, 132: 373-379.
  • 10Thenappan T, Shah SJ, Rich S, et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J, 2007, 30: 1103-1110.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部